Outcomes of Patients (PTS) with Unfavourable, Nonsquamous Cancer of Unknown Primary (CUP) Progressing After Induction Chemotherapy (CTX) in the Global, Open-Label, Phase II Cupisco Study

dc.contributor.author Bochtler, T.
dc.contributor.author Kraemer, A.
dc.contributor.author Pauli, C.
dc.contributor.author Duran-Pacheco, G.
dc.contributor.author Arslan, C.
dc.contributor.author Bigot, F.
dc.contributor.author Mileshkin, L.
dc.date.accessioned 2026-02-25T15:07:31Z
dc.date.available 2026-02-25T15:07:31Z
dc.date.issued 2024
dc.description.sponsorship F. Hoffmann-La Roche Ltd. en_US
dc.description.sponsorship F. Hoffmann-La Roche Ltd. en_US
dc.identifier.doi 10.1016/j.annonc.2024.08.2205
dc.identifier.issn 0923-7534
dc.identifier.issn 1569-8041
dc.identifier.uri https://doi.org/10.1016/j.annonc.2024.08.2205
dc.identifier.uri https://hdl.handle.net/20.500.14365/8680
dc.language.iso en en_US
dc.publisher Elsevier en_US
dc.relation.ispartof Annals of Oncology en_US
dc.rights info:eu-repo/semantics/openAccess en_US
dc.title Outcomes of Patients (PTS) with Unfavourable, Nonsquamous Cancer of Unknown Primary (CUP) Progressing After Induction Chemotherapy (CTX) in the Global, Open-Label, Phase II Cupisco Study en_US
dc.type Conference Object en_US
dspace.entity.type Publication
gdc.author.wosid Pazo-Cid, Roberto/Aah-3844-2020
gdc.author.wosid Mustafa, Özgüroğlu/A-8234-2016
gdc.author.wosid Pauli, Chantal/Htt-4689-2023
gdc.author.wosid Italiano, Antoine/Jrw-6637-2023
gdc.collaboration.industrial true
gdc.description.department İEÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü en_US
gdc.description.departmenttemp [Bochtler, T.] Heidelberg Univ, German Canc Ctr DKFZ, Clin Operat Unit Mol Hematol Oncol, Dept Internal Med 5, Heidelberg, Germany; [Bochtler, T.] Heidelberg Univ, German Canc Ctr DKFZ, Dept Med Oncol, Heidelberg, Germany; [Bochtler, T.] Heidelberg Univ Hosp, Natl Ctr Tumor Dis, Heidelberg, Germany; [Kraemer, A.] German Canc Res Ctr, Clin Operat Unit Mol Hematol Oncol, Heidelberg, Germany; [Kraemer, A.] German Canc Res Ctr, Dept Internal Med 5, Heidelberg, Germany; [Kraemer, A.] Heidelberg Univ, Heidelberg, Germany; [Pauli, C.; Moch, H.] Univ Hosp Zurich, Dept Pathol & Mol Pathol, Zurich, Switzerland; [Pauli, C.; Moch, H.] Univ Zurich, Zurich, Switzerland; [Duran-Pacheco, G.; Chalabi, N.] F Hoffmann La Roche Ltd, Global Product Dev Med Affairs, Basel, Switzerland; [Arslan, C.] Izmir Univ Econ Med Point Hosp, Dept Med Oncol, Izmir, Turkiye; [Bigot, F.] Inst Cancerol Ouest, Dept Med Oncol, Angers, France; [Cook, N.] Christie NHS Fdn Trust, Manchester, Lancs, England; [Cook, N.] Univ Manchester, Fac Biol Med & Hlth, Div Canc Sci, Manchester, Lancs, England; [Italiano, A.] Inst Bergonie, Early Phase Trials Unit, Bordeaux, France; [Italiano, A.] Inst Bergonie, Sarcoma Unit, Bordeaux, France; [Losa, F.] ICO Hosp, Hosp St Joan Despi Moises Broggi, Med Oncol Dept, Barcelona, Spain; [Menezes, J.] Ctr Pesquisa Integrado Oncol, Clin Oncol, Porto Alegre, RS, Brazil; [Ma, N.] Genentech Inc, Prod Dev Safety PDS, San Francisco, CA USA; [Ozguroglu, M.] Istanbul Univ Cerrahpasa, Fac Med, Dept Internal Med, Div Med Oncol,Clin Trial Unit, Istanbul, Turkiye; [Pazo Cid, R. A.] Miguel Servet Univ Hosp, Dept Med Oncol, Zaragoza, Spain; [Ross, J. S.] Fdn Med Inc, Pathol Grp, Cambridge, MS USA; [Ross, J. S.] SUNY Upstate Med Univ, Dept Pathol, Urol & Med Oncol, Syracuse, NY USA; [Shiu, K-K.] UCL Canc Inst, Canc Unknown Primary Serv, UCLH Gastrointestinal Oncol Serv, London, England; [Arni, P.] Evang Kliniken Essen Mitte, Dept Med Oncol, Essen, Germany; [Mileshkin, L.] Peter MacCallum Canc Ctr, Dept Med Oncol, Melbourne, Vic, Australia en_US
gdc.description.endpage S297 en_US
gdc.description.publicationcategory Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı en_US
gdc.description.scopusquality Q1
gdc.description.startpage S296 en_US
gdc.description.volume 35 en_US
gdc.description.woscitationindex Science Citation Index Expanded - Conference Proceedings Citation Index - Science
gdc.description.wosquality Q1
gdc.identifier.openalex W4402565611
gdc.identifier.wos WOS:001326612900200
gdc.index.type WoS
gdc.openalex.collaboration International
gdc.openalex.fwci 0.5845
gdc.openalex.normalizedpercentile 0.73
gdc.virtual.author Arslan, Çağatay
relation.isAuthorOfPublication e39c1203-60be-410a-97b3-27cb69d126a9
relation.isAuthorOfPublication.latestForDiscovery e39c1203-60be-410a-97b3-27cb69d126a9
relation.isOrgUnitOfPublication 7b4bd652-27ef-4beb-a10e-dddd2d65e0fd
relation.isOrgUnitOfPublication fbc53f3e-d1d3-4168-afd8-e42cd20bddd9
relation.isOrgUnitOfPublication e9e77e3e-bc94-40a7-9b24-b807b2cd0319
relation.isOrgUnitOfPublication.latestForDiscovery 7b4bd652-27ef-4beb-a10e-dddd2d65e0fd

Files